Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Gold, Boston,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 30th June 2025
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Gold, Amcomri,
Pound strengthens amid easing US inflation.
The British pound has experienced an increase against the US dollar, fueled by expectations that the Federal Reserve might reduce interest rates in the first half of the year due
Russia mulls fresh mobilisation of half-a-million conscripts for Ukraine
The Kremlin is still refusing to confirm speculation but quietly removed a rule that exempted fathers with three or more children from mobilization
Traders Cafe with Zak Mir: Bulletin Board Heroes, Sunday 22nd May 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Boston, DeepVerge, Europa, Harvest, MyHealth, Mila,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 3rd May 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Arc, Borders, Boston, Chill, Clontarf, Card,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 25th April 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Boston, Drumz, Empire, Genedrive, Keras, Live,
Kremlin Insider Arrested in U.S. Hacking and Insider-Trading
Russian technology executive with links to the Kremlin has pleaded not guilty U.S. to charges that led to an insider trading ring that made multi-millions of dollars hacking into systems
NASDAQ:TLSA | LSE:TILS: Foralumab Now in CAR T
On September 2nd, Tiziana Life Sciences PLC (NASDAQ:TLSA) (LSE:TILS) announced an exclusive licensing agreement with Precision BioSciences (NASDAQ:DTIL) for the exploration and development of foralumab as a lymphodepletion agent to
Tiziana Life Science (TILS.L) TLSA to Host Call to Discuss Exclusive License
Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment
Tiziana Life Sciences plc (TILS.L) Posting of Scheme Document and Notice of Meetings
London/New York, 3 September 2021 – Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) (“Old Tiziana”) a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases
Tiziana Life Science (TILS.L) License Agreement to Evaluate Foralumab with CAR T
Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment